Inventor
KAPLAN JOHANNE
US17 patents
⚠️ This page may combine multiple inventors who share the name “KAPLAN JOHANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EVELO BIOSCIENCES INC
7 patentsUS9610307B2Apr 4, 2017
Probiotic compositions containing clostridiales for inhibiting inflammation
EVELO BIOSCIENCES INC129 citations98
US9603878B2Mar 28, 2017
Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
EVELO BIOSCIENCES INC50 citations95
US10980845B2Apr 20, 2021
Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome
EVELO BIOSCIENCES INC11 citations93
US11607432B2Mar 21, 2023
Probiotic compositions containing clostridiales for inhibiting inflammation
EVELO BIOSCIENCES INC4 citations85
US10869903B2Dec 22, 2020
Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
EVELO BIOSCIENCES INC7 citations82
US11612622B2Mar 28, 2023
Probiotic compositions containing clostridiales for inhibiting inflammation
EVELO BIOSCIENCES INC1 citations72
US11672834B2Jun 13, 2023
Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome
EVELO BIOSCIENCES INC0 citations62
GENZYME CORP
5 patentsUS6100086AAug 8, 2000
Transgene expression systems
GENZYME CORP55 citations95
US6358507B1Mar 19, 2002
Transgene expression systems
GENZYME CORP18 citations92
US7014848B1Mar 21, 2006
Enhanced anti-tumor immunity
GENZYME CORP2 citations62
US9744233B2Aug 29, 2017
Methods of treating autoimmune diseases
GENZYME CORP0 citations51
US6485720B2Nov 26, 2002
Transgene expression systems
GENZYME CORP0 citations51
UNIV BRITISH COLUMBIA
4 patentsUS12404321B2Sep 2, 2025
Conformation-specific epitopes in alpha-synuclein, antibodies thereto and methods related thereof
UNIV BRITISH COLUMBIA0 citations57
US12071472B2Aug 27, 2024
Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers
UNIV BRITISH COLUMBIA0 citations54
US12559548B2Feb 24, 2026
Antibodies to misfolded TDP-43 and methods of use
UNIV BRITISH COLUMBIA0 citations51
US12286469B2Apr 29, 2025
Humanized antibodies binding to amyloid-beta (A-beta)
UNIV BRITISH COLUMBIA0 citations44